# Presentation: 351250

## SBIR ADVANCED TECHNOLOGY

- National Institute of Allergy & Infectious Diseases

**Notes:**
Good morning.  For the next five minutes or so, I will give you on overview of our SBIR-AT-NIAID.

## SBIR ADVANCED TECHNOLOGY				           PAR-98-073

- What is the SBIR-AT-NIAID ?
- Project Period & Amount of Award
- Areas of Interest
- History
- Review Criteria

**Notes:**
Listed are the topics I plan to cover.

## SBIR ADVANCED TECHNOLOGY				           PAR-98-073

- What is the SBIR-AT-NIAID ?

**Notes:**
The SBIR-AT-NIAID is the Small business Innovation Research Advanced Technology Announcement for the National Institute of Allergy & Infectious Diseases.  We invite grant applications under the announcement PAR-98-073 with projects with award duration and amounts greater than those routinely allowed under the SBIR program.

## SBIR ADVANCED TECHNOLOGY				           PAR-98-073

- Project Period & Amount of Award
-                _**Regular SBIR**_			    _**SBIR-AT-NIAID**_
**          ****Amount / Time Period**                  **Amount / Time Period**
**                                              ****Phase I**
-          **$100,000 / 6 to 12 mos.****	****        $300,000 per year / up to 2 years**
**                                             ****Phase II**
**         ****$750,000 / 2 years                     1 million per year / up to 3 years**
**                                             ****Phase III**
**               ****Commercialization without additional federal funds**

**Notes:**
Advanced technology projects are defined as those that include high-cost advanced technology or high cost long-term clinical studies in human or non-human primates.  Read chart.  Application receipt dates are the same: April 1st, August 1st and December 1st.

## SBIR ADVANCED TECHNOLOGY				           PAR-98-073

- Areas of Interest
**Development of vaccines, biologics, drugs, and prevention strategies for infectious and immunologic diseases, allergy, and transplantation.**
**Development of vaccine biologic and drug delivery systems.**
**Development of assays and therapeutic monitoring systems for clinical and vaccine trials.**

**Notes:**
This is our list of interest.  Our program staff is available to discuss your ideas.

## SBIR ADVANCED TECHNOLOGY				           PAR-98-073

- History
**PA was initially issued in May 1998**
**110 applications received**
**13 have been funded **

**Notes:**
The PA was initially issued in May 1998.  To date, 110 applications have been received.  Of the 110 applications, 7 are yet to be peer reviewed.  Of the remaining 103, 16 applications were assigned to other ICs.; I of the 16 was funded.  Of the 81 assigned to NIAID, 12 have been funded. One additional one may be funded. Overall, this is a 12% funding rate. 

## SBIR ADVANCED TECHNOLOGY				           PAR-98-073

- Review Criteria
- Review criteria is the same as a regular SBIR.

**Notes:**
The review criteria is the same as a regular SBIR.  That criteria is found in our purple solicitation manual, PHS 2000-2.  The phase I application should specify clear, measurable goals/milestones that should be achieved prior to initiating Phase II.  Failure to do that may result in an application to be judged as non-competitive.

## SBIR ADVANCED TECHNOLOGY				           PAR-98-073

- Come See Us

**Notes:**
For those of you that want to use this mechanism, it is suggested that you talk to our program staff as you begin to develop your plans.  Further, you must obtain agreement from NIAID that the application will be accepted for consideration for award, $500,000 or over.  We have a table here... our program staff is available to talk to you about the process and about the science.  Thank very you.